CHDR Solutions

  1. Immune Challenge Models For Early Drug Development 10/9/2025

    Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.

  2. Clinical Pharmacokinetics And Pharmacometrics 4/11/2025

    Learn about a sophisticated suite of pharmacokinetic (PK) and pharmacometric services designed to accelerate and optimize early-phase drug development.

  3. Clinical Trial Regulations 4/11/2025

    This essential guide walks through mastering the complex landscape of clinical trial regulations, providing a clear, practical breakdown of regulatory timelines, legal obligations, and more.

  4. Recruitment Strategies: A Behind The Scenes Look 4/9/2025

    Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.

  5. Innovative Dermatological Assessments For Early Drug Development 4/8/2025

    Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.

  6. Gain Objective Measures And Subjective Measures Of CNS Function 3/28/2025

    NeuroCart is a fully self-contained, mobile CNS test battery developed in-house at CHDR, offering the possibility to measure a wide range of CNS effects in a pharmacological context.

  7. Measuring A Wide Range Of CNS Effects In A Pharmacological Context 3/28/2025

    With nearly three decades of successful application, NeuroCart remains a gold standard in CNS pharmacology, supporting precise, data-driven decisions in drug development.

  8. Enable Value-Based Evaluation Of Medicines 3/28/2025

    Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.